K042704 · Elekon Industries U.S.A., Inc. · DQA · Nov 26, 2004 · Cardiovascular
Device Facts
Record ID
K042704
Device Name
REUSABLE FINGER CLIP SPO2 SENSORS
Applicant
Elekon Industries U.S.A., Inc.
Product Code
DQA · Cardiovascular
Decision Date
Nov 26, 2004
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.2700
Device Class
Class 2
Attributes
Pediatric
Intended Use
The Flexi-Stat SpO2 Sensor is indicated for continuous, non-invasive functional arterial oxygen saturation and pulse rate monitoring.
Device Story
Flexi-Stat SpO2 Sensor is an electro-optical accessory for pulse oximeters; functions without skin penetration, electrical contact, or heat transfer. Device utilizes two LEDs and one photodiode housed in a spring-loaded finger clip to measure light absorption of functional arterial hemoglobin. Sensor connects to oximeter via DB-9 cable (with adapter options). Used in clinical settings for continuous monitoring of oxygen saturation and pulse rate. Output is processed by the host oximeter to provide real-time physiological data, assisting clinicians in patient status assessment and decision-making.
Clinical Evidence
Clinical hypoxia studies conducted in an independent research lab. Subject device compared to arterial blood samples analyzed on a laboratory co-oximeter. Results demonstrated equivalence to predicate device accuracy claims. Biocompatibility, electrical safety, and EMC testing performed per industry standards.
Technological Characteristics
Electro-optical sensor; rigid spring-loaded clip housing; two LEDs and one photodiode; DB-9 connector; non-invasive; reusable. Conforms to biocompatibility, electrical safety, and EMC industry standards.
Indications for Use
Indicated for continuous, non-invasive functional arterial oxygen saturation and pulse rate monitoring in patients weighing >20 kg.
Regulatory Classification
Identification
An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.
K042705 — DISPOSABLE NON-ADHESIVE SPO2 SENSORS · Elekon Industries U.S.A., Inc. · Dec 29, 2004
K042675 — FLEXI-STAT SP02 EAR SENSOR · Elekon Industries U.S.A., Inc. · Dec 6, 2004
Submission Summary (Full Text)
{0}------------------------------------------------
NOV 2 6 2004
Appendix C Page 1 of 2
K042704
# 510(k) Summary
#### Submitter Information:
Elekon Industries, USA, Inc. 3848 Del Amo Blvd. Torrance CA 90503 USA
## Contact:
Tom Dietiker, President Tel: 310-370-8022 Fax:310-861-5619
## Date Prepared:
September 13, 2004
#### Product Name:
Common Name: SpO2 Sensor (accessory to pulse oximeter) Trade Name(s): Flexi-Stat SpO2 Sensors
#### Predicate Device:
The proposed devices are identical to the devices cleared under K041647 with the exception of added pediatric claims.
#### Description:
The Flexi-Stat(tm) SpO2 Sensor is an electro-optical sensor that functions without skin penetration, electrical contact, or heat transfer. The sensor uses optical means to determine the light absorption of functional arterial hemoglobin by being connected between the patient and the oximeter. The sensor contains three optical components: two light emitting diodes (LED) that serve as light sources and one photodiode that acts as a light detector. The optical components are housed in a rigid, spring-loaded clip. The sensor cable is terminated in a DB-9 style connector, with an adapter cable for Datex-compatible models.
#### Intended Use:
The Flexi-Stat SpO2 Sensor is indicated for continuous, non-invasive functional arterial oxygen saturation and pulse rate monitoring.
{1}------------------------------------------------
## Comparison to Predicate Device:
The Flexi-Stat SpO2 Sensor uses the same theory and principle of operation as the predicate device. Design characteristics are equivalent in terms of safety and effectiveness, as demonstrated by product testing and accuracy claims.
## Performance Data & Conclusions:
Performance testing was conducted during clinical hypoxia studies conducted in an independent research lab. The Flexi-Stat was compared to arterial blood samples analyzed on a laboratory co-oximeter and found to be equivalent to predicate device accuracy claims.
Biocompatibility, electrical safety, and EMC testing was also performed to demonstrate conformance with established industry standards.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of an eagle with three stripes representing the department's mission to protect the health of all Americans and provide essential human services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 26 2004
Elekon Industries USA, Incorporated C/O Ms. Krista Oakes Amica Solutions 2300 McDermott Road, #200-207 Plano, Texas 75025
Re: K042704
Trade/Device Name: Flexi-Stat™ Reusable Finger Clip Sp02 Sensors Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: September 29, 2004 Received: October 4, 2004
Dear Ms. Oakes:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Page 2 - Ms. Oakes
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Clas
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) # (if known):
Device Name: Flexi-Stat™ Reusable Finger Clip SpO2 Sensors
Indications for Use:
The Flexi-Stat SpO2 Sensor is indicated for continuous, non-invasive functional arterial oxygen saturation and pulse rate monitoring in patients weighing >20 kg.
Prescription Use _ x (21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Cees Soglione
(Division Sign-Off) (Division of Anesthesiology, General Hospital, Infection Control, Dental Devic
510(k) Number:
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.